Trends in Outcomes of Major Intracerebral Haemorrhage in a National Cohort of Very Preterm Born Infants in Switzerland.
grade 3 intraventricular haemorrhage
major intraventricular haemorrhage
mortality
neurodevelopment
outcome
periventricular
periventricular haemorrhagic infarction
preterm infant
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
19 Aug 2023
19 Aug 2023
Historique:
received:
26
07
2023
revised:
14
08
2023
accepted:
18
08
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
Major brain lesions, such as grade 3 intraventricular haemorrhage (G3-IVH) and periventricular haemorrhagic infarction (PVHI) are among the main predictors for poor neurodevelopment in preterm infants. In the last decades advancements in neonatal care have led to a general decrease in adverse outcomes. To assess trends of mortality and neurodevelopmental impairment (NDI) in a recent Swiss cohort of very preterm infants with grade 3 intraventricular haemorrhage (G3-IVH) and periventricular haemorrhagic infarction (PVHI). In this retrospective population-based cohort study, rates of mortality, and NDI at 2 years corrected age were reported in infants born at 24-29 weeks gestational age (GA) in Switzerland in 2002-2014, with G3-IVH and/or PVHI. Out of 4956 eligible infants, 462 (9%) developed G3-IVH (n = 172) or PVHI (n = 290). The average mortality rates for the two pathologies were 33% (56/172) and 60% (175/290), respectively. In 2002-2014, no change in rates of mortality (G3-IVH, In 2002-2014, rates of mortality and NDI in very preterm born infants with major brain lesions did not change. The significant decrease in mean GA and changing hospital policies over this time span may factor into the interpretation of these results.
Sections du résumé
BACKGROUND
BACKGROUND
Major brain lesions, such as grade 3 intraventricular haemorrhage (G3-IVH) and periventricular haemorrhagic infarction (PVHI) are among the main predictors for poor neurodevelopment in preterm infants. In the last decades advancements in neonatal care have led to a general decrease in adverse outcomes.
AIM
OBJECTIVE
To assess trends of mortality and neurodevelopmental impairment (NDI) in a recent Swiss cohort of very preterm infants with grade 3 intraventricular haemorrhage (G3-IVH) and periventricular haemorrhagic infarction (PVHI).
METHODS
METHODS
In this retrospective population-based cohort study, rates of mortality, and NDI at 2 years corrected age were reported in infants born at 24-29 weeks gestational age (GA) in Switzerland in 2002-2014, with G3-IVH and/or PVHI.
RESULTS
RESULTS
Out of 4956 eligible infants, 462 (9%) developed G3-IVH (n = 172) or PVHI (n = 290). The average mortality rates for the two pathologies were 33% (56/172) and 60% (175/290), respectively. In 2002-2014, no change in rates of mortality (G3-IVH,
CONCLUSION
CONCLUSIONS
In 2002-2014, rates of mortality and NDI in very preterm born infants with major brain lesions did not change. The significant decrease in mean GA and changing hospital policies over this time span may factor into the interpretation of these results.
Identifiants
pubmed: 37628411
pii: children10081412
doi: 10.3390/children10081412
pmc: PMC10453192
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Swiss National Science Foundation
ID : PZOOP3_161146
Pays : Switzerland
Références
Pediatrics. 2009 Jan;123(1):313-8
pubmed: 19117897
J Pediatr. 1978 Apr;92(4):529-34
pubmed: 305471
Pediatrics. 1998 Oct;102(4 Pt 1):893-9
pubmed: 9755261
Dev Med Child Neurol Suppl. 2007 Feb;109:8-14
pubmed: 17370477
Dev Med Child Neurol. 1990 Jan;32(1):30-45
pubmed: 2298334
Pediatrics. 2009 Jun;123(6):1493-500
pubmed: 19482759
Pediatr Neurol. 2006 Aug;35(2):85-92
pubmed: 16876002
Pediatrics. 2009 Dec;124(6):e1153-60
pubmed: 19948617
Biol Neonate. 1992;62(4):231-42
pubmed: 1420621
Arch Dis Child Fetal Neonatal Ed. 2008 May;93(3):F201-6
pubmed: 17768152
Pediatrics. 2006 Jun;117(6):2111-8
pubmed: 16740854
Brain Dev. 1986;8(1):25-30
pubmed: 3486608
Swiss Med Wkly. 2011 Oct 18;141:w13280
pubmed: 22009720
Pediatrics. 2009 Aug;124(2):e249-57
pubmed: 19651566
Pediatrics. 2001 Apr;107(4):719-27
pubmed: 11335750
BMC Pediatr. 2012 Dec 28;12:198
pubmed: 23272671
J Perinatol. 2014 Mar;34(3):203-8
pubmed: 24370654
Dev Med Child Neurol. 1997 Apr;39(4):214-23
pubmed: 9183258
Pediatrics. 2008 Jul;122(1):e46-52
pubmed: 18541618
Pediatr Res. 2014 May;75(5):670-4
pubmed: 24492622
Pediatrics. 2014 Jan;133(1):55-62
pubmed: 24379238
Pediatr Res. 2020 Mar;87(Suppl 1):13-24
pubmed: 32218535
Arch Dis Child Fetal Neonatal Ed. 2020 Mar;105(2):145-150
pubmed: 31201252
J Neurosurg Pediatr. 2015 Jun;15(6):580-8
pubmed: 26030329